CD8A and neoplasm: The importance of pre-existing, clonally restricted CD8 T-cell responses and of physical proximity between PD-1+ and PD-L1+ cells in the TME for tumor regression after immunotherapy with PD-1 blocking agents has again been demonstrated in patients with metastatic melanoma [23].